BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

206 related articles for article (PubMed ID: 11942034)

  • 1. [Effectiveness of postoperative radio- and chemotherapy in N(+) esophageal carcinoma].
    Sack H
    Strahlenther Onkol; 2002 Feb; 178(2):109-10. PubMed ID: 11942034
    [No Abstract]   [Full Text] [Related]  

  • 2. Who profits from neoadjuvant radiochemotherapy for locally advanced esophageal carcinoma?
    Elsaleh H; Farrell JJ; Crane CH
    J Gastroenterol Hepatol; 2009 May; 24(5):708-10. PubMed ID: 19646012
    [No Abstract]   [Full Text] [Related]  

  • 3. [Postoperative adjuvant therapies for esophageal carcinoma].
    Kuwano H; Ojima H; Kato H
    Gan To Kagaku Ryoho; 2000 Nov; 27(13):2023-7. PubMed ID: 11103232
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Improved local control by surgery and paclitaxel-based chemoradiation for esophageal squamous cell carcinoma: results of a retrospective non-randomized study.
    Hsu FM; Lin CC; Lee JM; Chang YL; Hsu CH; Tsai YC; Lee YC; Cheng JC
    J Surg Oncol; 2008 Jul; 98(1):34-41. PubMed ID: 18449912
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Long-term results of a phase II trial of neoadjuvant chemotherapy followed by esophagectomy for locally advanced esophageal neoplasm.
    Pennathur A; Luketich JD; Landreneau RJ; Ward J; Christie NA; Gibson MK; Schuchert M; Cooper K; Land SR; Belani CP
    Ann Thorac Surg; 2008 Jun; 85(6):1930-6; discussion 1936-7. PubMed ID: 18498797
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The multidisciplinary management of gastrointestinal cancer. Multimodal treatment of oesophageal cancer.
    Veuillez V; Rougier P; Seitz JF
    Best Pract Res Clin Gastroenterol; 2007; 21(6):947-63. PubMed ID: 18070697
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Factors affecting postoperative course and survival after en bloc resection for esophageal carcinoma.
    Mariette C; Taillier G; Van Seuningen I; Triboulet JP
    Ann Thorac Surg; 2004 Oct; 78(4):1177-83. PubMed ID: 15464466
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Combined therapy of inoperable esophageal cancer].
    Fink U; Pfeiffer G; Gossmann A; Lukas P; Wilke HJ; Preusser P; Siewert JR
    Z Gastroenterol Verh; 1991 Mar; 26():209-16. PubMed ID: 1714151
    [No Abstract]   [Full Text] [Related]  

  • 9. [Prospective non-randomized study of chemotherapy combined with radiotherapy versus chemotherapy alone in patients with metastatic or relapsed esophageal squamous cell carcinoma].
    Zhang XD; Shen L; Li J; Li Y; Li J; Zhang XT; Jin ML
    Zhonghua Zhong Liu Za Zhi; 2007 Jun; 29(6):474-7. PubMed ID: 17974288
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Should adjuvant or neoadjuvant treatment be administered in esophageal cancer?].
    Bedenne L
    Ann Chir; 1997; 51(6):605-10. PubMed ID: 9406457
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Making sense of multimodality therapy for esophageal cancer.
    Krasna MJ; Mao YS
    Surg Oncol Clin N Am; 1999 Apr; 8(2):259-78. PubMed ID: 10339645
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Squamous cell cancer of the esophagus. Treatment concept at the surgical clinic of the Munich Technical University].
    Siewert JR; Bartels H; Bollschweiler E; Dittler HJ; Fink U; Hölscher AH; Roder JD
    Chirurg; 1992 Sep; 63(9):693-700. PubMed ID: 1382922
    [No Abstract]   [Full Text] [Related]  

  • 13. Post-operative chemotherapy improves disease-free survival, but not overall survival in people with oesophageal squamous cell carcinoma.
    Leonard GD; Reilly EM
    Cancer Treat Rev; 2004 Aug; 30(5):473-7. PubMed ID: 15245779
    [No Abstract]   [Full Text] [Related]  

  • 14. [Neoadjuvant therapy in oesophageal cancer surgery].
    Imdahl A
    Zentralbl Chir; 2006 Apr; 131(2):105-9. PubMed ID: 16612775
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Impact of preoperative radiochemotherapy on postoperative course and survival in patients with locally advanced squamous cell oesophageal carcinoma.
    Mariette C; Piessen G; Lamblin A; Mirabel X; Adenis A; Triboulet JP
    Br J Surg; 2006 Sep; 93(9):1077-83. PubMed ID: 16779882
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Progress of postoperative adjuvant therapies for esophageal cancer].
    Terashima M; Kogure M; Gotoh M
    Gan To Kagaku Ryoho; 2002 Dec; 29(13):2475-80. PubMed ID: 12506469
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Induction chemotherapy improved outcomes of patients with resectable esophageal cancer who received chemoradiotherapy followed by surgery.
    Jin J; Liao Z; Zhang Z; Ajani J; Swisher S; Chang JY; Jeter M; Guerrero T; Stevens CW; Vaporciyan A; Putnam J; Walsh G; Smythe R; Roth J; Yao J; Allen P; Cox JD; Komaki R
    Int J Radiat Oncol Biol Phys; 2004 Oct; 60(2):427-36. PubMed ID: 15380576
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Adjuvant treatment of cancers of the esophagus].
    Tiret E; Fourquier P
    Gastroenterol Clin Biol; 1994; 18(8-9):714-8. PubMed ID: 7875439
    [No Abstract]   [Full Text] [Related]  

  • 19. Refining esophageal cancer staging after neoadjuvant therapy: importance of treatment response.
    Barbour AP; Jones M; Gonen M; Gotley DC; Thomas J; Thomson DB; Burmeister B; Smithers BM
    Ann Surg Oncol; 2008 Oct; 15(10):2894-902. PubMed ID: 18663531
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Squamous cell cancer of the esophagus. Treatment concept at the Cologne University surgical clinic].
    Pichlmaier H; Müller JM; Zieren U
    Chirurg; 1992 Sep; 63(9):701-8. PubMed ID: 1395874
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 11.